Americans taking Paxil CR extended release (paroxetine) may soon have one more option when it comes to buying their prescriptions. According to United Press International, the US Food and Drug Administration tentatively approved a generic version of Paxil CR extended release tablets on May 31, 2007. The drug becomes eligible for final FDA approval on June 29, 2007, when GlaxoSmithKline's patent expires.
The generic drug-manufacturer Mylan is set to make the generic version of Paxil, which will go by the name paroxetine extended-release tablets. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) prescribed to treat depression, dysthymia, panic disorder, social anxiety disorder and premenstrual dysphoric disorder. One of its most popular off-label uses is as a treatment for premature ejaculation.
For more info on selective serotonin reuptake inhibitors, including their pharmacology and medical uses, read this.
1 readers have commented on this article:
Hey mate. I would like a link exchange with my site www.managing-depresion.com .
Post a Comment